Sponsor Pipeline

Voyager Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-13 NCT07764146 An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's… Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06874621 VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study… Alzheimer's Disease (AD) Active, Not Recruiting
Phase 1
NCT07764146 An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's… Alzheimer s Disease Not Yet Recruiting
Disease Areas
Alzheimer's Disease (2)
Get alerts when Voyager Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free